This page shows you the latest news items in this category. This is page number 15.
Total 3232 results found since Jan 2013.
Italy: Health System Review
Health Syst Transit. 2022 Dec;24(4):1-236.ABSTRACTThis analysis of the Italian health system reviews recent developments in organization and governance, health financing, health care provision, health reforms and health system performance. Italy has a regionalized National Health Service (SSN) that provides universal coverage largely free of charge at the point of delivery, though certain services and goods require a co-payment. Life expectancy in Italy is historically among the highest in the EU. However, regional differences in health indicators are marked, as well as in per capita spending, distribution of health profes...
Source: Health systems in transition - March 23, 2023 Category: Health Management Authors: Antonio Giulio de Belvis Michela Meregaglia Alisha Morsella Andrea Adduci Alessio Perilli Fidelia Cascini Alessandro Solipaca Giovanni Fattore Walter Ricciardi Anna Maresso Giada Scarpetti Source Type: news
As CRA restarts child benefit clawbacks, parents scramble to make ends meet
The Canada Revenue Agency has resumed collecting debts tied to overpayments of the Canada Child Benefit, a move that some parents say resulted in drastic reductions of their benefit payments for March. The tax agency normally reduces or withholds tax refunds and benefit payments to offset a…#canadarevenueagency #canadachildbenefit #cra #saintjohn #rhiannoncormier #ccb #sylviebranch #canadians #hodgkin #stresstest
Source: Reuters: Health - March 22, 2023 Category: Consumer Health News Source Type: news
China EV Stocks Rise Despite Latest Warning Sign; XPEV Stock Pops
China EV stocks rose broadly early Tuesday despite a report of shift reductions by Chinese EV giant BYD (BYDFF) as demand weakens in the world's biggest and fastest-growing market for electric vehicles. X BYD, which outsells Tesla (TSLA) in China, asked some workers at its Xian plant to work only…#byd #xian #qinev #shenzhen #han #yuanplus #bydstock #teslanioliauto #nionio #xpeng
Source: Reuters: Health - March 21, 2023 Category: Consumer Health News Source Type: news
Blend of nine herbs could offer 'significantly greater' reductions in blood sugar - study
Packed with natural ingredients like turmeric, the supplement has shown promising blood sugar reductions in research.
Source: Daily Express - Health - March 19, 2023 Category: Consumer Health News Source Type: news
A Controversial Technology Is Creating an Unprecedented Rift Among Climate Scientists
If you can think of something, there’s probably a scientist studying it. There are researchers looking into naked mole rat breeding patterns, the aerodynamics of cricket balls, and that people tend to like pizza better than beans. But there are also certain experiments that scientists generally don’t do. They don’t, for instance, genetically modify humans, or clone them. They don’t conduct psychology experiments without subjects’ informed consent. And there’s a whole host of experimental medical procedures that could teach us a lot, but no one would ever be justified to try.
[time-brigh...
Source: TIME: Science - March 17, 2023 Category: Science Authors: Alejandro de la Garza Tags: Uncategorized climate change healthscienceclimate Source Type: news
Another one! Sanofi joins growing list of insulin manufacturers to cap cost of life-saving drug
Sanofi has become the third company to announce the price cuts of up to 78 percent. Novo Nordisk and Eli Lilly have revealed similar reductions to their insulin prices.
Source: the Mail online | Health - March 17, 2023 Category: Consumer Health News Source Type: news
Sanofi Is Now the Third Insulin Producer to Slash Prices
Sanofi will cut the U.S. list price of two of its insulins, making it the third major producer of the diabetes medicine to recently slash prices.
French pharmaceutical maker Sanofi will reduce the U.S. list price of Lantus, its most-prescribed insulin, by 78%, according to a statement Thursday. The company will also reduce the list price of Apidra by 70%.
“We are pleased to see others join our efforts to help patients as we now accelerate the transformation of the U.S. insulin market,” said Olivier Bogillot, the head of U.S. general medicines. “Our decision to cut the list price of our lead insulin needs ...
Source: TIME: Health - March 17, 2023 Category: Consumer Health News Authors: Ilena Peng/Bloomberg Tags: Uncategorized bloomberg wire Drugs healthscienceclimate Source Type: news
